In ₹ Crore except Per Share 12 Months Ending | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|
| Revenue from Operations | 309.3 | 659.4 | 389.9 | 401.4 | 422.7 | |
| Other Income | 14.8 | 31.3 | 21.2 | 24.3 | 26.1 | |
| Total Income | 324.1 | 690.7 | 411.1 | 425.7 | 448.8 | |
| Expenses | ||||||
| + Purchases of Stock-in-Trade | 10.1 | 36.5 | 34.1 | 25.6 | 27.7 | |
| + Changes in Inventories | 0.0 | -0.4 | -0.7 | 0.5 | -0.2 | |
| + Employee Benefit Expense | 20.0 | 44.9 | 23.5 | 24.2 | 23.6 | |
| + Finance Costs | 109.9 | 216.7 | 112.3 | 119.2 | 127.2 | |
| + Depreciation & Amortisation | 143.0 | 299.2 | 169.2 | 177.0 | 187.9 | |
| + Other Expenses | 91.1 | 182.5 | 95.7 | 103.1 | 113.1 | |
| Total Expenses | 374.1 | 779.4 | 434.2 | 449.6 | 479.3 | |
| EBITDA | 188.1 | 396.0 | 237.3 | 248.1 | 258.5 | |
| EBIT | 45.1 | 96.8 | 68.1 | 71.0 | 70.6 | |
| Profit | ||||||
| PBT before Exceptional Items | -50.0 | -88.7 | -23.1 | -23.9 | -30.5 | |
| Pretax Income | -50.0 | -88.7 | -23.1 | -23.9 | -30.5 | |
| + Current Tax | 3.9 | 6.9 | 6.1 | 8.8 | 8.2 | |
| + Deferred Tax | -17.1 | -28.9 | -12.1 | -10.0 | -14.8 | |
| Tax Expense | -13.2 | -22.0 | -6.0 | -1.2 | -6.6 | |
| Net Income | -36.8 | -66.6 | -17.1 | -22.7 | -23.9 | |
| + Net Income — Continuing Ops | -36.8 | -66.6 | -17.1 | -22.7 | -23.9 | |
| + Other Comprehensive Income | -0.4 | -0.7 | 1.3 | 0.3 | 0.2 | |
| Total Comprehensive Income | -37.1 | -67.3 | -15.8 | -22.3 | -23.7 | |
| Per Share | ||||||
| Basic EPS | -2.01 | -3.46 | -0.81 | -1.07 | -238.83 | |
| Diluted EPS | -2.01 | -3.46 | -0.81 | -1.07 | -238.83 | |
| Other Comprehensive Income — detail | ||||||
| + Other Comprehensive Income | -0.4 | -0.7 | 1.3 | 0.3 | 0.2 | |
| + Items NOT to be Reclassified to P&L | -0.5 | -1.0 | 1.7 | 0.5 | 0.3 | |
| + Tax on Items NOT to be Reclassified | -0.1 | -0.2 | 0.4 | 0.1 | 0.1 | |
| Per Share — as-filed variants | ||||||
| Basic EPS — Continuing Operations | -2.01 | -3.46 | -0.81 | -1.07 | -238.83 | |
| Diluted EPS — Continuing Operations | -2.01 | -3.46 | -0.81 | -1.07 | -238.83 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | ||||||
| Related-party Transactions — During the Period | — | 38.6 | — | 53.0 | — | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | ||||||
| Gross Profit | 299.2 | 623.3 | 356.5 | 375.3 | 395.3 | |
| Gross Margin % | 96.75 | 94.53 | 91.43 | 93.50 | 93.51 | |
| Adjusted (ex-Exceptional Items) — derived | ||||||
| Pretax Income (Adjusted, as filed) | -50.0 | -88.7 | -23.1 | -23.9 | -30.5 | |
| Net Income Adj (tax-effected) | -36.8 | -66.6 | -17.1 | -22.7 | -23.9 | |
| EPS Adj | -2.01 | -3.46 | -0.81 | -1.07 | -238.83 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | ||||||
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Paid Up Equity Capital | 18.3 | 21.0 | 21.2 | 21.2 | 21.2 | |